Shares of Phio Pharmaceuticals PHIO rallied 52.5% on Wednesday after the company announced that the Safety Monitoring ...

ICE Bioscience has developed the ICESTP Safety Panel 90 to offer drug developers a comprehensive secondary safety pharmacology assessment. This powerful new tool is designed to improve drug safety ...

Such an active/proactive approach, while maintaining focus on ADR detection, could also aim to extend knowledge of safety, such that emerging changes in risk–benefit during a drug's marketed ...

The Food and Drug Administration licenses vaccines, but clinicians wait for recommendations from the CDC advisory panel to understand ... regarding the benefits and safety of recommended vaccines ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...

Shares of Phio Pharmaceuticals PHIO rallied 52.5% on Wednesday after the company announced that the Safety Monitoring Committee (SMC) has recommended dose escalation in an early-stage study of the ...

ADR reporting is critical for drug safety monitoring and should be considered a professional responsibility. Increased educational efforts are needed to up-skill undergraduates and postgraduates ...

The SMC’s decision allowing escalation to the next dose concentration was based on the favorable safety profile of the drug observed in the third cohort of the phase Ib study, which enrolled three ...